<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>18(7)</volume><submitter>EFSA Panel on Nutrition, Novel foods and Food Allergens (NDA)</submitter><pubmed_abstract>Following an application from DuPont Nutrition Biosciences ApS submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Ireland, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to &lt;i>Bifidobacterium animalis&lt;/i> subsp. &lt;i>lactis&lt;/i> Bi-07 (Bi-07) and contribution to increasing lactose digestion. The scope of the application was proposed to fall under a health claim based on newly developed scientific evidence. The food proposed by the applicant as the subject of the health claim is Bi-07. The Panel considers that Bi-07 is sufficiently characterised. The claimed effect proposed by the applicant is 'improvem</pubmed_abstract><journal>EFSA journal. European Food Safety Authority</journal><pagination>e06198</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7388145</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>&lt;i>Bifidobacterium animalis&lt;/i> subsp. &lt;i>lactis&lt;/i> Bi-07 contributes to increasing lactose digestion: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006.</pubmed_title><pmcid>PMC7388145</pmcid><pubmed_authors>Kearney J</pubmed_authors><pubmed_authors>Vinceti M</pubmed_authors><pubmed_authors>Naska A</pubmed_authors><pubmed_authors>Castenmiller J</pubmed_authors><pubmed_authors>Pelaez C</pubmed_authors><pubmed_authors>McArdle HJ</pubmed_authors><pubmed_authors>Tsabouri S</pubmed_authors><pubmed_authors>Mangelsdorf I</pubmed_authors><pubmed_authors>Knutsen HK</pubmed_authors><pubmed_authors>Thies F</pubmed_authors><pubmed_authors>EFSA Panel on Nutrition, Novel foods and Food Allergens (NDA)</pubmed_authors><pubmed_authors>Maciuk A</pubmed_authors><pubmed_authors>De Henauw S</pubmed_authors><pubmed_authors>Pentieva K</pubmed_authors><pubmed_authors>Turck D</pubmed_authors><pubmed_authors>Hirsch-Ernst KI</pubmed_authors><pubmed_authors>Siani A</pubmed_authors><pubmed_authors>S Bresson JL</pubmed_authors></additional><is_claimable>false</is_claimable><name>&lt;i>Bifidobacterium animalis&lt;/i> subsp. &lt;i>lactis&lt;/i> Bi-07 contributes to increasing lactose digestion: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006.</name><description>Following an application from DuPont Nutrition Biosciences ApS submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Ireland, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to &lt;i>Bifidobacterium animalis&lt;/i> subsp. &lt;i>lactis&lt;/i> Bi-07 (Bi-07) and contribution to increasing lactose digestion. The scope of the application was proposed to fall under a health claim based on newly developed scientific evidence. The food proposed by the applicant as the subject of the health claim is Bi-07. The Panel considers that Bi-07 is sufficiently characterised. The claimed effect proposed by the applicant is 'improvem</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jul</publication><modification>2025-04-03T22:14:09.477Z</modification><creation>2020-11-19T13:33:19Z</creation></dates><accession>S-EPMC7388145</accession><cross_references><pubmed>32742434</pubmed><doi>10.2903/j.efsa.2020.6198</doi></cross_references></HashMap>